Decision Aid for Chemotherapy in Cisplatin-Intolerant Patients With Locally Advanced Cervical Cancer

Inclusion Criteria: * Squamous, adeno- or adenosquamous histology * International Federation of Gynaecology and Obstetrics (FIGO) Stage I-B3, II-A2, II-B to IV-A * Contraindication to ChT, including but not limited to hydronephrosis, renal or cardiac dysfunction, frailty, or refusal * Grade 6 level English literacy * Informed consent Exclusion Criteria: * Other histologies * Metastatic disease * Other active cancers * Prior cancer EXCEPT for a cancer treated curatively, in remission for ≥5 years, with low recurrence risk; adequately treated lentigo maligna or non-melanoma skin cancer without evidence of disease; or adequately treated carcinoma-in-situ without evidence of disease * Prior pelvic radiotherapy, brachytherapy, or chemotherapy * Pregnancy * Cognitive impairment or psychological disturbance limiting study compliance